Coronary artery disease and coronary artery bypass grafting in Behçet's disease

Mesut Sismanoglu1, Suat Nail Omeroglu, Denyan Mansuroglu

  • 1Kosuyolu Heart and Research Hospital, Istanbul, Turkey. msismanoglu@kosuyolu.gov.tr

Journal of Cardiac Surgery
|February 24, 2005
PubMed

Insights

Behçet's disease patients with coronary artery disease (CAD) face high pseudoaneurysm risks after coronary artery bypass grafting (CABG). A conservative approach is advised due to fragile tissues, with on-pump surgery recommended if CABG is necessary.

Area of Science:

  • Cardiovascular Surgery
  • Rheumatology
  • Vascular Surgery

Background:

  • Behçet's disease is associated with a high incidence of pseudoaneurysm formation.
  • Inflamed and fragile tissues in Behçet's disease patients pose surgical challenges.
  • Coronary artery disease (CAD) is rare in Behçet's disease, typically affecting young males.

Purpose of the Study:

  • To report the long-term outcomes of coronary artery bypass grafting (CABG) in patients with Behçet's disease.
  • To evaluate the safety and efficacy of surgical versus medical management for CAD in this patient population.
  • To highlight the risks of pseudoaneurysm formation in Behçet's disease patients undergoing cardiovascular procedures.

Main Methods:

  • Retrospective case series of five patients with Behçet's disease and CAD.
  • Three patients underwent coronary artery bypass grafting (CABG).
  • Two patients were managed medically.

Main Results:

  • No early mortality or morbidity in the studied cohort.
  • One patient developed pseudoaneurysm of the ascending aorta and femoral artery, leading to late death.
  • Operated patients achieved Canadian Cardiovascular Society (CCS) Class I, while medically treated patients were in CCS Class II at follow-up (mean 41 months).

Conclusions:

  • A conservative management strategy is recommended for Behçet's disease patients with CAD due to high post-operative pseudoaneurysm risk.
  • If CABG is unavoidable, performing the procedure off-pump with minimal aortic manipulation is advised.
  • Long-term results of CABG in Behçet's disease patients are scarce, underscoring the need for cautious management.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...